Blar i Bergen Open Research Archive på forfatter "Hurissa, Mengistu Bekele"
-
Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia
Hailu, Alemayehu; Norheim, Ole Frithjof; Hurissa, Mengistu Bekele (Journal article; Peer reviewed, 2021)Background. Metformin is a widely accepted first-line pharmacotherapy for patients with type 2 diabetes mellitus (T2DM). Treatment of T2DM with glibenclamide, saxagliptin, or one of the other second-line treatment agents ...